Endometrial Adenocarcinoma Heterogeneity of Progesterone Receptor Distribution in Human Updated


The clinical response of advanced endometrial adenocarcinoma to progestin therapy does not correlate perfectly with biochemically assayed progesterone receptor status of the tumor. We have previously suggested that heterogeneity of progesterone receptor at the cellular, tumor, and tissue levels, not detectable by the biochemical assay, might contribute to… (More)

11 Figures and Tables


  • Presentations referencing similar topics